Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Tianbiao Yang"'
Autor:
Lifan Chen, Zisheng Fan, Jie Chang, Ruirui Yang, Hui Hou, Hao Guo, Yinghui Zhang, Tianbiao Yang, Chenmao Zhou, Qibang Sui, Zhengyang Chen, Chen Zheng, Xinyue Hao, Keke Zhang, Rongrong Cui, Zehong Zhang, Hudson Ma, Yiluan Ding, Naixia Zhang, Xiaojie Lu, Xiaomin Luo, Hualiang Jiang, Sulin Zhang, Mingyue Zheng
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-21 (2023)
Abstract Drug development based on target proteins has been a successful approach in recent decades. However, the conventional structure-based drug design (SBDD) pipeline is a complex, human-engineered process with multiple independently optimized st
Externí odkaz:
https://doaj.org/article/c4c90579e2754437ac6717ad301ee041
Autor:
Xiaowei Wu, Mengdi Dai, Rongrong Cui, Yulan Wang, Chunpu Li, Xia Peng, Jihui Zhao, Bao Wang, Yang Dai, Dan Feng, Tianbiao Yang, Hualiang Jiang, Meiyu Geng, Jing Ai, Mingyue Zheng, Hong Liu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 3, Pp 781-794 (2021)
Fibroblast growth factor receptors (FGFRs) have emerged as promising targets for anticancer therapy. In this study, we synthesized and evaluated the biological activity of 66 pyrazolo[3,4-d]pyridazinone derivatives. Kinase inhibition, cell proliferat
Externí odkaz:
https://doaj.org/article/1ba935fbaca3438c82b23137c0971ab9
Autor:
Xiaozhe Wan, Tingyang Xu, Tianbiao Yang, Xutong Li, Xiaochu Tong, Xiaoqin Tan, Lifan Chen, Sulin Zhang, Chunpu Li, Ruirui Yang, Rongrong Cui, Hong Liu, Fei Li, Liu Xiaohong, Mingyue Zheng, Hualiang Jiang, Sen Zhao
Publikováno v:
Journal of Medicinal Chemistry. 65:103-119
Alterations of discoidin domain receptor1 (DDR1) may lead to increased production of inflammatory cytokines, making DDR1 an attractive target for inflammatory bowel disease (IBD) therapy. A scaffold-based molecular design workflow was established and
Autor:
Xiaolong Wu, Xiaomin Luo, Xiaozhe Wan, Tianbiao Yang, Xiaohong Liu, Feisheng Zhong, Yinghui Zhang, Kaixian Chen, Sulin Zhang, Dingyan Wang, Xutong Li, Ruirui Yang, Zunyun Fu, Zisheng Fan, Mingyue Zheng, Hualiang Jiang
Publikováno v:
Protein & Cell
A fundamental challenge that arises in biomedicine is the need to characterize compounds in a relevant cellular context in order to reveal potential on-target or off-target effects. Recently, the fast accumulation of gene transcriptional profiling da
Autor:
Meng-di Dai, Xiaowei Wu, Rongrong Cui, Tianbiao Yang, Xia Peng, Meiyu Geng, Mingyue Zheng, Jihui Zhao, Jing Ai, Yulan Wang, Hualiang Jiang, Chunpu Li, Bao Wang, Hong Liu, Dan Feng, Yang Dai
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 3, Pp 781-794 (2021)
Fibroblast growth factor receptors (FGFRs) have emerged as promising targets for anticancer therapy. In this study, we synthesized and evaluated the biological activity of 66 pyrazolo[3,4-d]pyridazinone derivatives. Kinase inhibition, cell proliferat
Publikováno v:
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 169
Serious eye damage and eye irritation have been authenticated to be significant human health issues in various fields such as ophthalmic pharmaceuticals. Due to the shortcomings of traditional animal testing methods, in silico methods have advanced t
Autor:
Lifan Chen, Zisheng Fan, Jie Chang, Ruirui Yang, Hao Guo, Yinghui Zhang, Tianbiao Yang, Chenmao Zhou, Zhengyang Chen, Chen Zheng, Xinyue Hao, Keke Zhang, Rongrong Cui, Yiluan Ding, Naixia Zhang, Xiaomin Luo, Hualiang Jiang, Sulin Zhang, Mingyue Zheng
Drug development based on target proteins has been a successful approach in recent decades. A conventional structure-based drug design pipeline is a complex, human-engineered pipeline with multiple independently optimized steps. Advances in end-to-en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd7e30f471740aa45f71c31cde35ca6
https://doi.org/10.1101/2022.03.26.485909
https://doi.org/10.1101/2022.03.26.485909
Autor:
Cheng-Long Hu, Bing-Yi Chen, Zijuan Li, Tianbiao Yang, Chun-Hui Xu, Ruirui Yang, Peng-Cheng Yu, Jingyao Zhao, Ting Liu, Na Liu, Bin Shan, Qunling Zhang, Junhong Song, Ming-Yue Fei, Li-Juan Zong, Jia-Ying Zhang, Ji-Chuan Wu, Shu-Bei Chen, Yong Wang, Binhe Chang, Dan Hou, Ping Liu, Yilun Jiang, Xiya Li, Xinchi Chen, Chu-Han Deng, Yi-Yi Ren, Roujia Wang, Jiacheng Jin, Kai Xue, Ying Zhang, Meirong Du, Jun Shi, Ling-Yun Wu, Chun-Kang Chang, Shuhong Shen, Zhu Chen, Sai-Juan Chen, Xiaolong Liu, Xiao-Jian Sun, Mingyue Zheng, Lan Wang
Publikováno v:
Cell research. 32(12)
Aberrant self-renewal of leukemia initiation cells (LICs) drives aggressive acute myeloid leukemia (AML). Here, we report that UHRF1, an epigenetic regulator that recruits DNMT1 to methylate DNA, is highly expressed in AML and predicts poor prognosis
Autor:
Guangchao Wang, Tianbiao Yang, Yingjia Chen, Zhaojun Li, Jihui Zhao, Xiaomin Luo, Zunyun Fu, Xiaoqin Tan, Mingyue Zheng, Hualiang Jiang, Dan Feng, Kaixian Chen, Xiaoyu Ding
Publikováno v:
Nucleic Acids Research
One of the most prominent topics in drug discovery is efficient exploration of the vast drug-like chemical space to find synthesizable and novel chemical structures with desired biological properties. To address this challenge, we created the DrugSpa
Autor:
Dingyan Wang, Xiaohong Liu, Kaixian Chen, Feisheng Zhong, Xiaomin Luo, Mingyue Zheng, Hualiang Jiang, Xiaoqin Tan, Lifan Chen, Tianbiao Yang
Publikováno v:
Bioinformatics. 36:4406-4414
Motivation Identifying compound–protein interaction (CPI) is a crucial task in drug discovery and chemogenomics studies, and proteins without three-dimensional structure account for a large part of potential biological targets, which requires devel